Nine lawsuits against Bayer Healthcare Pharmaceuticals alleging the company’s Mirena IUD caused neurological conditions will not be consolidated into a multidistrict litigation because there are just too few to justify the motion. Plaintiffs had asked that the lawsuits be centralized in Tennessee; Bayer opposed centralization or to have them consolidated in New York.
Bayer already faces multidistrict litigation with its Mirena intrauterine device over uterine perforation, a different injury.
These nine lawsuits claim that the Mirena IUD contraceptive device releases a synthetic hormone that can cause neurological problems, including a type of brain damage known as pseudo tumor cerebra (PTC) or idiopathic intracranial hypertension (IIH).
PTC or IIH are rare, affecting about 3.3 of 100,000 women between the ages of 15 and 44. However, exposure to Levonorgestrel could increase the chances of developing the condition. Levonorgestrel is the hormone that is released by the Mirena IUD.
The safety label for the Mirena IUD does not include any warnings of PTC or IIH, which plaintiffs say means that once patients are diagnosed, most doctors do not know to advise patients to have their IUDs removed in order to stop progression of the disease.
Women who have used the Mirena IUD and experienced any serious side effects or injuries of any kind should consult with an attorney. Lawyers with Beasley Allen Law Firm are investigating adverse effects of the Mirena IUD and are available for consultation.